Peptide

Thymosin Alpha-1

An immune-modulating peptide used clinically in some jurisdictions for specific indications.

AvailabilityClinical & regulatory review required

A consultation does not guarantee that a product can be supplied.

Background

What it is, how it developed and why it is discussed

Thymosin alpha-1 is a naturally occurring thymic peptide with immunomodulatory activity. Pharmaceutical products have been used in some countries for defined clinical indications, but regulatory approval is jurisdiction-specific.

Evidence

Evidence, limitations and clinical context

South African registration, indication and scheduling must be confirmed for the specific product before supply.

Clinical access

Availability requires regulatory confirmation

Online purchase remains disabled until the exact human-use product, South African registration and scheduling have been verified. A clinical assessment can still be booked to discuss appropriate options.

Clinical assessment Clinician authorisation